Cargando…
Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants
Gastrointestinal stromal tumors (GISTs) are rare but treatable soft tissue sarcomas. Nearly all GISTs have somatic mutations in either the KIT or PDGFRA gene, but there are no known inherited genetic risk factors. We assessed the relationship between KIT/PDGFRA mutations and select deletions or sing...
Autores principales: | O'Brien, Katie M., Orlow, Irene, Antonescu, Cristina R., Ballman, Karla, McCall, Linda, DeMatteo, Ronald, Engel, Lawrence S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630216/ https://www.ncbi.nlm.nih.gov/pubmed/23637977 http://dx.doi.org/10.1371/journal.pone.0062119 |
Ejemplares similares
-
Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations
por: O’Brien, Katie M, et al.
Publicado: (2013) -
SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors
por: Italiano, Antoine, et al.
Publicado: (2012) -
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
por: Joensuu, Heikki, et al.
Publicado: (2014) -
Somatic pharmacogenomics of gastrointestinal stromal tumor
por: Ravegnini, Gloria, et al.
Publicado: (2019) -
Imatinib potentiates anti-tumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
por: Balachandran, Vinod P., et al.
Publicado: (2011)